Yongzhen Liu

Prof. Yongzhen Liu

Medical School, Nanjing University, Nanjing, Jiangsu, China
orcid

Biography

Dr. Liu got his PhD at Peking University with the major of pathogenic organisms in 2019 and then did the postdoc at Princeton University from 2019 to 2024. In September 2024, Dr Liu joined Nanjing University and started his lab as a Principal investigator. Dr. Liu's research is focused on hepatitis viruses and liver cancer. Hepatitis B virus (HBV) is a major causative agent of chronic hepatitis, cirrhosis and hepatocellular carcinoma (HCC). HBV infection can be prevented with a prophylactic vaccine and antiviral therapy can suppress viremia but rarely leads to a cure and only decreases, but does not eliminate, the risk of further liver injury and HCC development. A major roadblock for developing more effective therapies and for gaining mechanistic insights into the pathogenesis of chronic hepatitis B is the scarcity of suitable animal models. Since Dr. Liu was a Ph.D. student, he have particular research interest on HBV and my research focus on the development of HCC, HBV virological characteristics, HBV animal model and its pathogenesis in the corresponding liver cancer. With specific training and expertise as a Ph.D. student and then postdoctoral researcher, Dr. Liu have a broad background in virology, cancer and animal model studies.

Affiliations

Nanjing University

Nanjing, Jiangsu, China

Medical School

Honors and Awards

honor

Postdoctoral Fellowship from NJCCR

NJCCR

Postdoctoral Fellowship from NJCCR for outstanding postdocs in NJ

Experience

Senior Scientist or Principal Investigator

Nanjing University, Nanjing, China

01 Dec 2024 - present

Post Doctoral Researcher

Princeton University, Princeton, USA

01 Jul 2019 - 01 Sep 2024

Graduate Student or Post Graduate

Peking University, Beijing, China

01 Sep 2014 - 01 Jun 2019